PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15232364-0	2004	Subnormal rise of erythropoietin in patients receiving interferon and ribavirin combination therapy for hepatitis C. OBJECTIVES: Anemia is a common complication during interferon-ribavirin therapy for hepatitis C. While normally a fall in hematocrit in results in an exponential compensatory rise in erythropoietin, such that the correlation between hematocrit and erythropoietin is sharply negative, the erythropoietin response during interferon-ribavirin combination therapy is not known.	Ribavirin	70-79	erythropoietin	Homo sapiens	18-32	
15232364-0	2004	Subnormal rise of erythropoietin in patients receiving interferon and ribavirin combination therapy for hepatitis C. OBJECTIVES: Anemia is a common complication during interferon-ribavirin therapy for hepatitis C. While normally a fall in hematocrit in results in an exponential compensatory rise in erythropoietin, such that the correlation between hematocrit and erythropoietin is sharply negative, the erythropoietin response during interferon-ribavirin combination therapy is not known.	Ribavirin	179-188	erythropoietin	Homo sapiens	18-32	
15232364-0	2004	Subnormal rise of erythropoietin in patients receiving interferon and ribavirin combination therapy for hepatitis C. OBJECTIVES: Anemia is a common complication during interferon-ribavirin therapy for hepatitis C. While normally a fall in hematocrit in results in an exponential compensatory rise in erythropoietin, such that the correlation between hematocrit and erythropoietin is sharply negative, the erythropoietin response during interferon-ribavirin combination therapy is not known.	Ribavirin	179-188	erythropoietin	Homo sapiens	18-32	
15232364-7	2004	There was an approximate 2 log10 reduction in maximal achievable erythropoietin level in subjects exposed to interferon-ribavirin combination.	Ribavirin	120-129	erythropoietin	Homo sapiens	65-79	
15232364-8	2004	CONCLUSION: There is a subnormal rise of erythropoietin after interferon-ribavirin combination therapy for hepatitis C.	Ribavirin	73-82	erythropoietin	Homo sapiens	41-55